In an interview with PharmaShots, Dr. Minnie Sarwal, CEO and Co-Founder of NephroSant shares her view on the QSant and how this urine test can improve outcomes for transplant patients. […]readmore
Tags : Precision Medicine
Shots: The two companies will develop and launch precision medicine strategies for CV, renal, and metabolic diseases. The first stage in the collaboration will use KidneyIntelX to improve outcomes for […]readmore
Shots: Pfizer and Synapse collaborate to advance the cancer outcomes research using real-world evidence and accelerate new cancer therapies for the improvement of patient’s health with an initial focus on […]readmore